In contrast to the limited frequency of individual gene mutations and fusion-genes mentioned above overexpression of Wilms Tumor 1 (WT1) mRNA is present in about 90% of patients with AML and 50% of patients with MDS. Here, WT1 is linked to acute myeloid leukemia.